Related Experiment Videos
Alpha-thalassaemia prenatal diagnosis by two PCR-based methods.
M Kleanthous1, K Kyriacou, A Kyrri
1The Cyprus Institute of Neurology and Genetics, PO Box 23462, Nicosia 1463, Cyprus. marinakl@mdrtc.cing.ac.cy
Prenatal Diagnosis
|May 22, 2001
Summary
Cyprus
Area of Science:
- Medical Genetics
- Molecular Biology
- Public Health
Background:
- Alpha-thalassemia is a genetic blood disorder.
- Carrier screening and prenatal diagnosis are crucial for managing alpha-thalassemia.
- Cyprus has a comprehensive thalassaemia carrier screening program.
Purpose of the Study:
- To evaluate the effectiveness of molecular methods for alpha-thalassemia prenatal diagnosis in Cyprus.
- To assess the accuracy of gap-PCR and (CA)n repeat polymorphism analysis.
- To ensure accurate risk assessment for couples carrying alpha-thalassemia mutations.
Main Methods:
- Utilized gap-PCR to identify parental alpha-thalassemia mutations.
- Employed (CA)n repeat polymorphism analysis for allele determination.
- Conducted molecular analysis on 46 couples with suspected alpha-thalassemia deletions.
Main Results:
- Identified 13 out of 46 couples at risk for Hb Bart's hydrops fetalis.
- Provided prenatal diagnosis for 16 pregnancies.
- Achieved accurate molecular diagnosis in all tested cases using both methods.
Conclusions:
- Dual molecular methods (gap-PCR and (CA)n repeat polymorphism) ensure accurate alpha-thalassemia prenatal diagnosis.
- The Cyprus screening program effectively identifies at-risk couples.
- No misdiagnosed cases of alpha-thalassemia were reported, highlighting diagnostic reliability.